Plethora
Plethora is a groundbreaking computer game, built in collaboration between researchers at the Weizmann Institute, Forex and MindCET. It’s a simple and pleasant entry point into the world of computer science, and helps develop complex problem-solving and computational thinking skills.
Quantum Source
Quantum Source develops the core processing elements for photonic quantum computers. The company is in stealth mode and more information will be revealed in the future.
Quantum Art
Quantum Art Ltd develops quantum computing system solutions, based on trapped ions. It is a spin-off from the Ozeri group at the Weizmann Institute of Science - the only group with a fully working quantum computer in Israel currently, with state of the art performance.
Exciting things are happening in the world of Cardiology
Yeda's spinoff company, UltraSight has announced that it has been granted a patent for real-time guidance of #ultrasound devices.
UltraLight is a #digitalhealth pioneer transforming cardiac imaging through the power of #AI. This technology aims to allow medical professionals with no prior sonography experience to accurately perform #echocardiographic examinations and acquire high quality diagnostic images of the #heart.
Read more:
Congratulations to Prof. Nir London
Congratulations to Prof. Nir London, winner of the Mark Foundation for Cancer 2023 Aspire Award.
The London lab develops and applies computational and experimental methods to design and discover new compounds for applications in chemical biology, drug discovery, and design, with a focus on covalent inhibition and kinase signaling.
Learn more about the London lab:
Yeda announces partnership with eureKARE, to establish EonBio!
Co-founded by eureKARE, an innovative European investment firm dedicated to building disruptive synthetic biology ventures and Yeda, EonBio is based on the groundbreaking research by Prof. Roy Bar-Ziv and his team at the Weizmann Institute of Science.
EonBio’s cutting-edge synthetic cell-free platform has the potential to revolutionize drug discovery, vaccine development, and bioproduction, empowering pharmaceutical companies to take on new challenges in their pursuit of more effective therapies.
For more information:
This Valentine’s Day, let’s take a moment to talk about Heart health. ❤️ ️
Did you know that heart disease is the leading cause of death worldwide, accounting for more deaths than all types of cancer combined? The impact it has on our society and healthcare system is staggering, with costs in the US alone reaching over $230 billion per year.
Stimulating Production and Extraction of Metabolites in Plants
It's no secret that plants carry unique properties, for centuries plants have been used for a range of applications, including food, drugs and cosmetics.
But did you know that the benefits of plants can now be used without any interference to the plant itself?
The team led by Professor. Asaph Aharoni, from the Weizmann Institute of Science, has developed a method of inducing metabolite production in plants and extracting them without any harm being done.
Discover how in our latest newsletter:
Revolutionary discovery places Xinteza at the forefront of cannabinoid sourcing
Innovative biosynthesis technology company, Xinteza API, recently made a breakthrough discovery of a novel, non-cannabis plant-derived production system, capable of highly efficient and flawless end-to-end cannabinoid synthesis. This discovery is a major milestone in the path to uncover and exploit rare and new cannabinoid molecules with potentially novel pharmacological activities.
Xinteza is a spinoff company of Yeda, while leading the research is Professor Asaph Aharoni from the Weizmann Institute of Science.
Pages
